Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0293218 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Thomas J Sproule und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, ME, United States of America. Hauptthemen laut MEDLINE: Dystonia, Dystonic Disorders, Epidermolysis Bullosa, Epidermolysis Bullosa Simplex. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DEBRA Austria, Debra International, Jackson Laboratory.
Abstract (Originalsprache)
The Lamc2 jeb junctional epidermolysis bullosa (EB) mouse model has been used to demonstrate that significant genetic modification of EB symptoms is possible, identifying as modifiers Col17a1 and six other quantitative trait loci, several with strong candidate genes including dystonin ( Dst/Bpag1 ). Here, CRISPR/Cas9 was used to alter exon 23 in mouse skin specific isoform Dst-e (Ensembl GRCm38 transcript name Dst-213, transcript ID ENSMUST00000183302.5, protein size 2639AA) and validate a proposed arginine/glutamine difference at amino acid p1226 in B6 versus 129 mice as a modifier of EB. Frame shift deletions (FSD) in mouse Dst-e exon 23 ( Dst-e FSD/FSD ) were also identified that cause mice carrying wild-type Lamc2 to develop a phenotype similar to human EB simplex without dystonia musculorum. When combined, Dst-e FSD/FSD modifies Lamc2 jeb/jeb (FSD+ jeb ) induced disease in unexpected ways implicating an altered balance between DST-e (BPAG1e) and a rarely reported rodless DST-eS (BPAG1eS) in epithelium as a possible mechanism. Further, FSD+ jeb mice with pinnae removed are found to provide a test bed for studying internal epithelium EB disease and treatment without severe skin disease as a limiting factor while also revealing and accelerating significant nasopharynx symptoms present but not previously noted in Lamc2 jeb/jeb mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Jackson Laboratory, Bar Harbor, ME, United States of America.
- Division of Dermatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Division of Microscopic Anatomy, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, United States of America.
ORCID-Profile: Thomas J Sproule, John J Wilson, Benjamin E Low, Michael V Wiles, John P Sundberg
Förderung
- DEBRA Austria
- Debra International
- Jackson Laboratory
Zitieren
APA
Sproule, T. J., Wilpan, R. Y., Wilson, J. J., Low, B. E., Kabata, Y., Ushiki, T., Abe, R., Wiles, M. V., Roopenian, D. C., & Sundberg, J. P. (2023). Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum. PLOS ONE. https://doi.org/10.1371/journal.pone.0293218
Vancouver
Sproule TJ, Wilpan RY, Wilson JJ, Low BE, Kabata Y, Ushiki T, et al. Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum. PLOS ONE. 2023. doi:10.1371/journal.pone.0293218
BibTeX
@article{Sproule2023,
author = {Sproule, Thomas J and Wilpan, Robert Y and Wilson, John J and Low, Benjamin E and Kabata, Yudai and Ushiki, Tatsuo and Abe, Riichiro and Wiles, Michael V and Roopenian, Derry C and Sundberg, John P},
title = {Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0293218}
}
EUVIMED